论文部分内容阅读
目的:探讨反流性食管炎采用洛赛克联合西沙比利治疗临床效果。方法:本次选取80例反流性食管炎患者,均为我院消化内科2013年4月至2014年4月收治,随机分组,就单用西沙比利治疗(对照组,n=40)与加用洛赛克治疗(观察组,n=40)效果展开对比。结果:观察组选取病例症状改善总有效率为95%,胃镜改善总有效率为85%,对照组分别为70%,62.5%,差异均有统计学意义(P<0.05)。结论:反流性食管炎采用洛赛克联合西少比利治疗,可显著改善临床症状,提高治疗效果,保障患者生活质量,具有非常重要的应用价值。
Objective: To investigate the clinical effect of Losec and cisapride on reflux esophagitis. Methods: A total of 80 patients with reflux esophagitis were enrolled in our hospital from April 2013 to April 2014. Patients were randomly divided into three groups: control group (n = 40) and cisapride Plus Losec treatment (observation group, n = 40) the effect of contrast. Results: The total effective rate of the selected cases in the observation group was 95%, the total effective rate of the gastroscopy was 85%, and the control group was 70% and 62.5% respectively (P <0.05). Conclusion: The treatment of reflux esophagitis by Losec combined with Xishaobili can significantly improve the clinical symptoms, improve the therapeutic effect and ensure the quality of life of patients, which is of great value in application.